Evox Therapeutics picks up $95.4m Series C
Evox Therapeutics Ltd, an exosome therapeutics company, has raised $95.4 million in a Series C financing.
Evox Therapeutics Ltd, an exosome therapeutics company, has raised $95.4 million in a Series C financing.
Copyright PEI Media
Not for publication, email or dissemination